Evogene Announces Pricing of US$8,500,000 Registered Direct Offering
REHOVOT, Israel, July 17, 2023 /PRNewswire/ — Evogene Ltd. (“Evogene”) (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discove…